Trial | NCT01305317  Report issue

Title

Effect of Statins on IgG, IgA and IgM Level in Chronic Hemodialysis Patients
Study of Statins' Effect on Serum IgG, IgA Ang IgM Level in Chronic Hemodialysis Patients

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    74
This is double blind randomized controlled trial on the statins effects on serum IgG, IgA and IgM level in chronic hemodialysis patients in Bandarabbas
This study is a randomized controlled trial of statins effect on serum IgG, IgA and IgM level on chronic hemodialysis patients in Bandarabbas. The study is carried out in Hormozgan, Iran. Seventy four patient were randomized either to receive atorvastatin in addition of usual treatment or not. The primary outcomes were serum IgG,IgA and IgM level. The secondary outcome was drug side effects.
Study Started
Jan 31
2007
Primary Completion
Jan 31
2008
Study Completion
Jan 31
2010
Last Update
Mar 01
2011
Estimate

Drug Lipitor

Atorvastatin 20mg daily for 6 months

  • Other names: atorvastatin, statins

lipitor Experimental

atorvastatin 20mg daily

Criteria 

Inclusion Criteria:

All chronic hemodialysis patients attending Shahid Mohammadi hospital during the study period
Accepting to participate in the study

Exclusion Criteria:

Refusing to participate in the study
No Results Posted